Cancer-related Stroke: Exploring Personalized Therapy Strategies

Overview

Journal Brain Behav

Specialty Psychology

Date 2022 Aug 8

PMID 35938982

Authors

Yu-Jie Chen

Rui-Guo Dong

Meng-Meng Zhang

Chao Sheng

Peng-Fei Guo

Jie Sun

Affiliations

Soon will be listed here.

Abstract

Background: Cancer and ischemic stroke are two common diseases that threaten human health and have become the main causes of death in the world. It is estimated that one-in-ten patients with ischemic stroke have concomitant cancer, and this incidence is expected to increase as improvements in medical technology extends the life expectancy of cancer patients.

Discussion: Cancer-related stroke (CRS) refers to unexplained ischemic stroke in patients with active cancer that cannot be explained by current stroke mechanisms. Available evidence suggests that CRS accounts for 5-10% of embolic stroke of undetermined source (ESUS). Although the incidence of CRS is gradually increasing, its underlying pathogenesis remains unclear. Also, there is no consensus on acute treatment and secondary prevention of stroke.

Conclusion: In this review, we retrospectively analyzed the incidence, mechanisms of CRS, its potential as a new stroke subtype, options for acute treatment, secondary prevention strategies, and disease progression, with the aim of attempting to explore personalized therapy strategies.

Citing Articles

The Influence of Cancer Type on Stroke Incidence: A Retrospective Study.

Acir I, Erdogan H, Toka E, Yayla V Clin Med Insights Oncol. 2024; 18:11795549241308090.

PMID: 39698497 PMC: 11653439. DOI: 10.1177/11795549241308090.

Population data study reveals pain as a possible protective factor against cerebrovascular disease in cancer patients.

Wei Y, Lin D, Lian Y, Wei Q, Zheng L, Yuan K Sci Rep. 2024; 14(1):29471.

PMID: 39604497 PMC: 11603069. DOI: 10.1038/s41598-024-80668-9.

Mechanical thrombectomy for the treatment of large vessel occlusion due to cancer-related cerebral embolism: A systematic review.

Toruno M, Al-Janabi O, Karaman I, Ghozy S, Senol Y, Kobeissi H Interv Neuroradiol. 2024; :15910199241230356.

PMID: 38332668 PMC: 11569766. DOI: 10.1177/15910199241230356.

Recurrent Multifocal Embolic Strokes in a 50-Year-Old Male: Unmasking Occult Squamous Cell Carcinoma.

Prabakar D, Sabesan V, Emenogu O, Mai C Cureus. 2023; 15(9):e45091.

PMID: 37842450 PMC: 10568952. DOI: 10.7759/cureus.45091.

Acute reperfusion treatment and secondary prevention of cancer-related stroke: comprehensive overview and proposal of clinical algorithm.

Aloizou A, Palaiodimou L, Aloizou D, Dardiotis E, Gold R, Tsivgoulis G Ther Adv Neurol Disord. 2023; 16:17562864231180717.

PMID: 37342814 PMC: 10278431. DOI: 10.1177/17562864231180717.

References

Catani M, Savini I, Tullio V, Gasperi V . The "Janus Face" of Platelets in Cancer. Int J Mol Sci. 2020; 21(3). PMC: 7037171. DOI: 10.3390/ijms21030788. View

Oldgren J, Wallentin L, Alexander J, James S, Jonelid B, Steg G . New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis. Eur Heart J. 2013; 34(22):1670-80. PMC: 3675388. DOI: 10.1093/eurheartj/eht049. View

Lee E, Bae J, Jeong H, Lee E, Jeong H, Yoon B . Effectiveness of mechanical thrombectomy in cancer-related stroke and associated factors with unfavorable outcome. BMC Neurol. 2021; 21(1):57. PMC: 7866628. DOI: 10.1186/s12883-021-02086-y. View

Yoo J, Nam H, Kim Y, Lee H, Heo J . Short-Term Outcome of Ischemic Stroke Patients With Systemic Malignancy. Stroke. 2019; 50(2):507-511. DOI: 10.1161/STROKEAHA.118.023044. View

Kawano H, Honda Y, Amano T, Okano H, Suzuki R, Torii M . Subcutaneous Heparin Therapy for Patients with Cancer-Associated Stroke. J Stroke Cerebrovasc Dis. 2018; 28(2):399-404. DOI: 10.1016/j.jstrokecerebrovasdis.2018.10.012. View

Nguyen T, DeAngelis L . Stroke in cancer patients. Curr Neurol Neurosci Rep. 2006; 6(3):187-92. DOI: 10.1007/s11910-006-0004-0. View

Murthy S, Karanth S, Shah S, Shastri A, Venkatasubba Rao C, Bershad E . Thrombolysis for acute ischemic stroke in patients with cancer: a population study. Stroke. 2013; 44(12):3573-6. DOI: 10.1161/STROKEAHA.113.003058. View

Shen Y, Li Y, Chen C, Wang W, Li T . D-dimer and diffusion-weighted imaging pattern as two diagnostic indicators for cancer-related stroke: A case-control study based on the STROBE guidelines. Medicine (Baltimore). 2020; 99(4):e18779. PMC: 7004795. DOI: 10.1097/MD.0000000000018779. View

Kim S, Hong J, Kim H, Lee J, Chung P, Park K . Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke. 2010; 41(4):798-801. DOI: 10.1161/STROKEAHA.109.571356. View

10.

Rogers L . Cerebrovascular complications in patients with cancer. Semin Neurol. 2010; 30(3):311-9. DOI: 10.1055/s-0030-1255224. View

11.

Saver J, Goyal M, Bonafe A, Diener H, Levy E, Pereira V . Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015; 372(24):2285-95. DOI: 10.1056/NEJMoa1415061. View

12.

Porfidia A, Porceddu E, Feliciani D, Giordano M, Agostini F, Ciocci G . Differences in Clinical Presentation, Rate of Pulmonary Embolism, and Risk Factors Among Patients With Deep Vein Thrombosis in Unusual Sites. Clin Appl Thromb Hemost. 2019; 25:1076029619872550. PMC: 6829629. DOI: 10.1177/1076029619872550. View

13.

Singh V, Bhat I, Havlin K . Marantic endocarditis (NBTE) with systemic emboli and paraneoplastic cerebellar degeneration: uncommon presentation of ovarian cancer. J Neurooncol. 2007; 83(1):81-3. DOI: 10.1007/s11060-006-9306-y. View

14.

Chow E, Chen Y, Hudson M, Feijen E, Kremer L, Border W . Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer. J Clin Oncol. 2017; 36(1):44-52. PMC: 5756324. DOI: 10.1200/JCO.2017.74.8673. View

15.

Navi B, Reiner A, Kamel H, Iadecola C, Elkind M, Panageas K . Association between incident cancer and subsequent stroke. Ann Neurol. 2014; 77(2):291-300. PMC: 4315703. DOI: 10.1002/ana.24325. View

16.

Wojtukiewicz M, Sierko E, Hempel D, Tucker S, Honn K . Platelets and cancer angiogenesis nexus. Cancer Metastasis Rev. 2017; 36(2):249-262. PMC: 5557865. DOI: 10.1007/s10555-017-9673-1. View

17.

Martinez-Majander N, Ntaios G, Liu Y, Ylikotila P, Joensuu H, Saarinen J . Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial. Eur J Neurol. 2020; 27(5):841-848. DOI: 10.1111/ene.14172. View

18.

Kearon C, Akl E, Ornelas J, Blaivas A, Jimenez D, Bounameaux H . Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016; 149(2):315-352. DOI: 10.1016/j.chest.2015.11.026. View

19.

Masrur S, Abdullah A, Smith E, Hidalgo R, El-Ghandour A, Rordorf G . Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy. J Stroke Cerebrovasc Dis. 2010; 20(2):124-30. DOI: 10.1016/j.jstrokecerebrovasdis.2009.10.010. View

20.

Wang J, Zhang G, Zhuo S, Wang K, Hu X, Zhang H . D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients. Neurol Res. 2018; 40(11):948-954. DOI: 10.1080/01616412.2018.1504179. View